Astria Therapeutics
ATXS
ATXS
23 hedge funds and large institutions have $11.8M invested in Astria Therapeutics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
12% less funds holding
Funds holding: 26 → 23 (-3)
72% less capital invested
Capital invested by funds: $42.1M → $11.8M (-$30.3M)
Holders
23
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$337K | |
| 2 | +$231K | |
| 3 | +$144K | |
| 4 |
Renaissance Technologies
New York
|
+$106K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$74K |
Top Sellers
| 1 | -$4.97M | |
| 2 | -$3.61M | |
| 3 | -$2.89M | |
| 4 |
DM
Deerfield Management
New York
|
-$2.46M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.01M |